Johnson & Johnson, Wyeth pull infant cold medications
Drug makers voluntarily pulled kids' cold medicines off the market less than two weeks after the US government warned of potential health risks to infants.
By Agencies |
WASHINGTON: Drug makers voluntarily pulled kids' cold medicines off the market less than two weeks after the US government warned of potential health risks to infants.
Products aimed at children under the age of 2 are being removed from store shelves due to "rare instances of misuse" that could lead to accidental overdose, a trade group that represents over-the-counter drug makers said yesterday. The group said parents should not use any medicines they have at home in infants.
The Consumer Healthcare Products Association said last month it agreed with government officials that use of the drugs should be restricted, but had previously stopped short of pulling the products from the market.
Cold medicines being withdrawn include Johnson & Johnson Pediacare Infant Drops and Tylenol Concentrated Infants Drops, Wyeth's Dimetapp Decongestant Infant Drops, Novartis' Triaminic Infant & Toddler Thin Strips and Prestige Brands Holdings' Little Colds Decongestant Plus Cough.
CVS Caremark Corp said yesterday it would remove the affected products as well as CVS-brand equivalents from store shelves.
Late last month, the Food and Drug Administration tentatively recommended adding the words "do not use in children under two years" to products' labeling. Current labeling directs parents to consult a doctor before administering the drugs to infants and toddlers.
Products aimed at children under the age of 2 are being removed from store shelves due to "rare instances of misuse" that could lead to accidental overdose, a trade group that represents over-the-counter drug makers said yesterday. The group said parents should not use any medicines they have at home in infants.
The Consumer Healthcare Products Association said last month it agreed with government officials that use of the drugs should be restricted, but had previously stopped short of pulling the products from the market.
Cold medicines being withdrawn include Johnson & Johnson Pediacare Infant Drops and Tylenol Concentrated Infants Drops, Wyeth's Dimetapp Decongestant Infant Drops, Novartis' Triaminic Infant & Toddler Thin Strips and Prestige Brands Holdings' Little Colds Decongestant Plus Cough.
CVS Caremark Corp said yesterday it would remove the affected products as well as CVS-brand equivalents from store shelves.
Late last month, the Food and Drug Administration tentatively recommended adding the words "do not use in children under two years" to products' labeling. Current labeling directs parents to consult a doctor before administering the drugs to infants and toddlers.
Download
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
The Economic Times Business News App for the Latest News in Business, Sensex, Stock Market Updates & More.
Download
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
The Economic Times News App for Quarterly Results, Latest News in ITR, Business, Share Market, Live Sensex News & More.
ADVERTISEMENT
